FDA Inspection 1077526 — MP Biomedicals Asia Pacific Pte Ltd
The FDA completed an inspection of MP Biomedicals Asia Pacific Pte Ltd on December 14, 2018 in Singapore. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 14, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Singapore (Singapore)